The LD 500 Archives - Page 11 of 21

WednesdaySep 02, 2020 11:20 am

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Starts Presentation at The LD 500

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. Tonix's portfolio is primarily composed of central nervous system (CNS) and immunology product candidates. The immunology portfolio includes vaccines to prevent infectious diseases and biologics to address immunosuppression, cancer and autoimmune diseases. The CNS portfolio includes both small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. Tonix's lead vaccine candidate, TNX-1800, is a live replicating vaccine, based on the horsepox viral vector platform, to protect against…

WednesdaySep 02, 2020 11:20 am

Aurora Solar Technologies Inc. (TSX.V: ACU) Starts Presentation at The LD 500

Aurora Solar Technologies Inc. (TSX.V: ACU) is a leader in the development and delivery of inline process measurement, analysis and control systems for solar cell manufacturers. Aurora believes that solar power will dominate the renewable energy field, and its mission is to bring quality and profitability to every customer through superior control of critical processes during solar cell manufacturing. Aurora's products are used by some of the world's most advanced and respected solar cell manufacturers. With headquarters near Vancouver, Aurora has operations in Shanghai and partners in all major solar manufacturing markets. For more information, visit the company's website at…

WednesdaySep 02, 2020 11:00 am

Envision Solar International Inc. (NASDAQ: EVSI) Starts Presentation at The LD 500

Envision Solar International Inc. (NASDAQ: EVSI) is the leading producer of unique and sustainable infrastructure products for electric vehicle charging, energy security and outdoor media, including the EV ARC(TM) and the Solar Tree(R) with EnvisionTrak(TM) patented solar tracking, SunCharge(TM) solar electric vehicle charging, ARC(TM) technology energy storage and EnvisionMedia(TM) solar advertising displays. Based in San Diego, California, the company produces 'made in America' products. For more information, visit the company's website at www.envisionsolar.com About The LD 500 The LD 500 is the most ambitious project in LD Micro's 14-year history of leading the micro-cap space as an independent resource. Investors…

WednesdaySep 02, 2020 11:00 am

Myomo Inc. (NYSE American: MYO) Starts Presentation at The LD 500

Myomo Inc. (NYSE American: MYO) is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line, a powered upper limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. It is currently the only marketed device that, sensing a patient's own EMG signals through non-invasive sensors on the arm, can restore an…

WednesdaySep 02, 2020 11:00 am

Magal Security Systems Ltd. (NASDAQ: MAGS) Starts Presentation at The LD 500

Magal Security Systems Ltd. (NASDAQ: MAGS) is a leading international provider of solutions and products for physical and cyber security, as well as safety and site management. Since 1969, Magal has delivered tailor-made security solutions and turnkey projects to hundreds of satisfied customers in over 100 countries – under some of the most challenging conditions. The company develops, manufactures, markets and sells complex computerized security systems, including cyber and physical security, safety and site management solutions and products. Its products include perimeter intrusion detection, video management, pipeline protection, personal duress and cyber security systems. For more information, visit the company's…

WednesdaySep 02, 2020 10:40 am

Ideal Power Inc. (NASDAQ: IPWR) Starts Presentation at The LD 500

Ideal Power Inc. (NASDAQ: IPWR) is pioneering the development of its broadly patented bi-directional power switches, creating highly efficient and eco-friendly energy control solutions for industrial, alternative energy, military and automotive applications. The company is focused on its patented bi-directional, bi-polar junction transistor (B-TRAN(TM)) semiconductor technology. B-TRAN is a unique double-sided bi-directional AC switch that's able to deliver substantial performance improvements over today's conventional power semiconductors. Ideal Power believes B-TRAN modules will reduce conduction and switching losses, complexity of thermal management and operating cost in medium-voltage AC power switching and control circuitry. For more information, visit the company's website at…

WednesdaySep 02, 2020 10:40 am

IEC Electronics Corp. (NASDAQ: IEC) Starts Presentation at The LD 500

IEC Electronics Corp. (NASDAQ: IEC) is a provider of electronic manufacturing services ("EMS") to advanced technology companies that produce lifesaving and mission-critical products for the medical, industrial, aerospace and defense sectors. The company specializes in delivering technical solutions for the custom manufacture of complex full system assemblies by providing on-site analytical testing laboratories, custom design and test engineering services combined with a broad array of manufacturing services encompassing electronics, interconnect solutions and precision metalworking. As a full-service EMS provider, IEC holds all appropriate certifications for the market sectors it supports, including ISO 9001:2015, AS9100D and ISO 13485, and the company…

WednesdaySep 02, 2020 10:40 am

Biocept Inc. (NASDAQ: BIOC) Starts Presentation at The LD 500

Biocept Inc. (NASDAQ: BIOC) is a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve patient outcomes. As a molecular diagnostics company with commercialized assays for lung, breast, gastric, colorectal and prostate cancers and melanoma, Biocept leverages its proprietary liquid biopsy technology to provide physicians with data for treating and monitoring patients diagnosed with cancer. The company's patented Target Selector(TM) liquid biopsy technology platform captures and analyzes tumor-associated molecular markers in both circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA). With thousands of tests performed, the platform has demonstrated the ability to…

WednesdaySep 02, 2020 10:20 am

Zedge Inc. (NYSE: ZDGE) Starts Presentation at The LD 500

Zedge Inc. (NYSE: ZDGE) offers a state-of-the-art digital publishing platform that powers its consumer-facing app, availing users with a host of digital content, including wallpapers, video wallpapers, ringtones and stickers. Zedge is developing new apps to run on top of its publishing platform and generally focuses on the entertainment vertical. Zedge creators are amateur and professional artists, as well as new and major brands who can easily launch a virtual storefront in Zedge where they can market and sell their content to the userbase. The Zedge app has been downloaded more than 436 million times, has nearly 30 million monthly…

WednesdaySep 02, 2020 10:20 am

CEL-SCI Corp. (NYSE American: CVM) Starts Presentation at The LD 500

CEL-SCI Corp. (NYSE American: CVM) believes boosting a patient's immune system while it is still intact should provide the greatest possible impact on survival. Therefore, in its global pivotal Phase 3 study, CEL-SCI treated patients who are newly diagnosed with advanced primary squamous cell carcinoma (cancer) of the head and neck with Multikine (leukocyte interleukin, injection) first, before they received surgery, radiation and/or chemotherapy. This approach is unique. Most other cancer immunotherapies are administered only after conventional therapies have been tried and/or failed. Multikine has received Orphan Drug Designation from the FDA for neoadjuvant therapy in patients with squamous cell…